- Corporate Officers - C
- Coles N Anthony
Insider Trading History of Coles N Anthony
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Coles N Anthony since 2008.
This trader's CIK number is 1197018.
At the time of last reporting, Coles N Anthony was the Officer of Cerevel Therapeutics Holdings, Inc.. (stock ticker symbol CERE).
Also see all insider trading activities at Cerevel Therapeutics Holdings, Inc..
Note that in the past
COLES N ANTHONY also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Nps Pharmaceuticals Inc (NPSP) by Coles N Anthony
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | NPSP | 0 | $0 | 0 | $0 | 45,000 | $0 |
Yearly summary of insider trading at Cerevel Therapeutics Holdings, Inc. (CERE) by Coles N Anthony
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CERE | 0 | $0 | 227,506 | $9,459,033 | 240,440 | $787,500 |
| 2023 | CERE | 0 | $0 | 477,176 | $13,423,961 | 477,176 | $1,670,115 |
Yearly summary of insider trading at Regeneron Pharmaceuticals, Inc. (REGN) by Coles N Anthony
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | REGN | 0 | $0 | 5,758 | $4,102,718 | 5,758 | $2,466,727 |
| 2021 | REGN | 0 | $0 | 19,948 | $13,014,866 | 19,948 | $7,103,393 |
| 2020 | REGN | 0 | $0 | 0 | $0 | 11 | $3,800 |
Yearly summary of insider trading at Mckesson Corp (MCK) by Coles N Anthony
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | MCK | 0 | $0 | 2,453 | $384,559 | 0 | $0 |
| 2018 | MCK | 0 | $0 | 1,350 | $173,731 | 0 | $0 |
Yearly summary of insider trading at Onyx Pharmaceuticals Inc (ONXX) by Coles N Anthony
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | ONXX | 0 | $0 | 38,834 | $3,450,705 | 34,778 | $1,113,082 |
| 2012 | ONXX | 0 | $0 | 416,992 | $21,073,356 | 375,599 | $11,289,855 |
| 2011 | ONXX | 0 | $0 | 21,093 | $748,210 | 0 | $0 |
| 2010 | ONXX | 0 | $0 | 44,167 | $1,282,092 | 0 | $0 |
| 2009 | ONXX | 0 | $0 | 13,609 | $374,197 | 0 | $0 |
Insider trading activities at 5 companies by Coles N Anthony:
1. Nps Pharmaceuticals Inc (NPSP)
2. Cerevel Therapeutics Holdings, Inc. (CERE)
3. Regeneron Pharmaceuticals, Inc. (REGN)
4. Mckesson Corp (MCK)
5. Onyx Pharmaceuticals Inc (ONXX)
Table 1. Insider trading of Nps Pharmaceuticals Inc (NPSP) by Coles N Anthony
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-11-02 | NPSP | Option Ex | 45,000 | .00 | 0 |
Table 2. Insider trading of Cerevel Therapeutics Holdings, Inc. (CERE) by Coles N Anthony
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-07-01 | CERE | Option Ex | 25,000 | 3.50 | 87,500 |
| 2024-07-01 | CERE | Sale | 25,000 | 41.18 | 1,029,524 |
| 2024-05-10 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2024-05-10 | CERE | Sale | 50,000 | 42.10 | 2,105,150 |
| 2024-03-04 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2024-03-04 | CERE | Sale | 50,000 | 41.01 | 2,050,550 |
| 2024-02-29 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2024-02-29 | CERE | Sale | 50,000 | 41.16 | 2,057,900 |
| 2024-02-07 | CERE | Sale | 2,506 | 41.54 | 104,109 |
| 2024-02-06 | CERE | Option Ex | 15,440 | .00 | 0 |
| 2024-01-02 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2024-01-02 | CERE | Sale | 50,000 | 42.24 | 2,111,800 |
| 2023-11-07 | CERE | Option Ex | 27,076 | 3.50 | 94,766 |
| 2023-11-08 | CERE | Option Ex | 100 | 3.50 | 350 |
| 2023-11-07 | CERE | Sale | 27,076 | 25.02 | 677,549 |
| 2023-11-08 | CERE | Sale | 100 | 25.16 | 2,516 |
| 2023-11-03 | CERE | Sale | 61,401 | 25.43 | 1,561,488 |
| 2023-11-02 | CERE | Sale | 38,599 | 25.19 | 972,231 |
| 2023-11-03 | CERE | Option Ex | 61,401 | 3.50 | 214,903 |
| 2023-11-02 | CERE | Option Ex | 38,599 | 3.50 | 135,096 |
| 2023-09-07 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2023-09-07 | CERE | Sale | 50,000 | 24.07 | 1,203,400 |
| 2023-07-11 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2023-07-11 | CERE | Sale | 50,000 | 30.03 | 1,501,350 |
| 2023-06-01 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2023-06-01 | CERE | Sale | 50,000 | 32.60 | 1,630,050 |
| 2023-05-04 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2023-05-04 | CERE | Sale | 50,000 | 32.02 | 1,600,850 |
| 2023-04-11 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
| 2023-04-11 | CERE | Sale | 50,000 | 25.06 | 1,253,150 |
| 2023-03-02 | CERE | Option Ex | 47,000 | 3.50 | 164,500 |
| 2023-03-03 | CERE | Option Ex | 3,000 | 3.50 | 10,500 |
| 2023-03-02 | CERE | Sale | 47,000 | 27.11 | 1,274,358 |
| 2023-03-03 | CERE | Sale | 3,000 | 27.19 | 81,570 |
| 2023-02-07 | CERE | Sale | 50,000 | 33.31 | 1,665,449 |
| 2023-02-07 | CERE | Option Ex | 50,000 | 3.50 | 175,000 |
Table 3. Insider trading of Regeneron Pharmaceuticals, Inc. (REGN) by Coles N Anthony
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-28 | REGN | Option Ex | 5,758 | 428.40 | 2,466,727 |
| 2022-12-28 | REGN | Sale | 5,758 | 712.52 | 4,102,718 |
| 2021-09-15 | REGN | Option Ex | 11,948 | 363.21 | 4,339,633 |
| 2021-09-15 | REGN | Sale | 11,948 | 658.26 | 7,864,866 |
| 2021-08-17 | REGN | Option Ex | 900 | 345.47 | 310,923 |
| 2021-08-18 | REGN | Option Ex | 5,100 | 345.47 | 1,761,897 |
| 2021-08-17 | REGN | Sale | 900 | 650.00 | 585,000 |
| 2021-08-18 | REGN | Sale | 5,100 | 650.00 | 3,315,000 |
| 2021-08-13 | REGN | Option Ex | 2,000 | 345.47 | 690,940 |
| 2021-08-13 | REGN | Sale | 2,000 | 625.00 | 1,250,000 |
| 2020-11-13 | REGN | Option Ex | 11 | 345.47 | 3,800 |
Table 4. Insider trading of Mckesson Corp (MCK) by Coles N Anthony
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-08-17 | MCK | Sale | 2,453 | 156.77 | 384,559 |
| 2018-08-31 | MCK | Sale | 1,350 | 128.69 | 173,731 |
Table 5. Insider trading of Onyx Pharmaceuticals Inc (ONXX) by Coles N Anthony
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-06-05 | ONXX | Option Ex | 6,562 | 35.18 | 230,851 |
| 2013-06-05 | ONXX | Sale | 6,562 | 90.00 | 590,580 |
| 2013-04-03 | ONXX | Option Ex | 17,278 | 28.79 | 497,433 |
| 2013-04-01 | ONXX | Sale | 11,629 | 86.14 | 1,001,722 |
| 2013-04-03 | ONXX | Sale | 9,705 | 90.06 | 873,983 |
| 2013-03-28 | ONXX | Option Ex | 10,938 | 35.18 | 384,798 |
| 2013-03-28 | ONXX | Sale | 10,938 | 90.00 | 984,420 |
| 2012-10-16 | ONXX | Option Ex | 125,599 | 32.10 | 4,032,355 |
| 2012-10-16 | ONXX | Sale | 125,599 | .00 | 0 |
| 2012-08-08 | ONXX | Option Ex | 250,000 | 29.03 | 7,257,500 |
| 2012-08-08 | ONXX | Sale | 270,690 | 72.18 | 19,538,404 |
| 2012-08-01 | ONXX | Sale | 8,820 | 74.37 | 655,943 |
| 2012-07-25 | ONXX | Sale | 11,883 | 73.97 | 879,009 |
| 2011-06-15 | ONXX | Sale | 8,845 | 36.10 | 319,286 |
| 2011-04-01 | ONXX | Sale | 12,248 | 35.02 | 428,924 |
| 2010-12-07 | ONXX | Sale | 13,669 | 32.00 | 437,408 |
| 2010-08-17 | ONXX | Sale | 7,375 | 26.96 | 198,830 |
| 2010-08-19 | ONXX | Sale | 12,625 | 26.08 | 329,209 |
| 2010-04-20 | ONXX | Sale | 1,576 | 29.95 | 47,201 |
| 2010-04-01 | ONXX | Sale | 8,922 | 30.20 | 269,444 |
| 2009-04-06 | ONXX | Sale | 7,500 | 27.31 | 204,825 |
| 2009-04-01 | ONXX | Sale | 6,109 | 27.73 | 169,372 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Coles N Anthony
(Officer of Cerevel Therapeutics Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.